Explore
Personalized Diagnosis and Therapy for Multiple Sclerosis
0 Ungluers have
Faved this Work
Login to Fave
We all agree that people with MS need to be cared in a profoundly personalized way. The care of the patient with MS is still based on the presence of relapses, so their successful diagnosis and treatment is fundamental and will condition the therapeutic strategies to follow with the patient. The treatment strategies are a highly controversial topic of debate that is increasingly supported by robust objective biological markers of response and that also increasingly take into account the dynamics and predictors of cognitive impairment along the disease course, which includes the adoption of new trends in the field of machine learning techniques. However, we all know that patient care goes beyond being treated with drugs and we cannot overlook reminding patients of the importance of their lifestyle behaviors that vary according to the MS phenotype, in order to improve their quality of life. Teleconsultation is a new care strategy proved to be feasible and well-received by patients with MS that will undoubtedly become reinforced because it will allow a closer follow-up of the patient without the need for displacement.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 45 times via unglue.it ebook links.
- 45 - pdf (CC BY) at Unglue.it.
Keywords
- artificial intelligence
- biomarker
- CD49d
- Cognition
- cognitive impairment
- digital health
- diseases modifying therapies
- early intense therapy
- escalating strategy
- extended interval dose
- feasibility
- he-DMT
- health-related quality of life
- immunomonitoring
- Internet
- lifestyle behavior
- Longitudinal
- Machine learning
- medicine
- Medicine: General Issues
- methylprednisolone
- mood
- MS management
- MS phenotype
- Multiple Sclerosis
- multiple sclerosis treatment
- n/a
- natalizumab
- neuroimaging
- neuromyelitis optica spectrum disorder
- personalized dose
- predictors
- prognosis
- pseudo-relapses
- Public health & preventive medicine
- Quality of life
- relapse
- sVCAM-1
- teleconsultation
- treatment algorithm
Links
DOI: 10.3390/books978-3-0365-5256-9Editions